Mersana Therapeutics, Inc.
MRSN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,545 | -$24,296 | -$24,123 | -$14,117 |
| Dep. & Amort. | $83 | $287 | $316 | $400 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,154 | $1,989 | $2,775 | $3,346 |
| Change in WC | $1,857 | -$2,067 | -$9,069 | -$9,187 |
| Other Non-Cash | $1,259 | $1,485 | $775 | $307 |
| Operating Cash Flow | -$3,192 | -$22,602 | -$29,326 | -$19,251 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $395 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $27,000 | $50,000 |
| Other Inv. Act. | $372 | $0 | $0 | $0 |
| Investing Cash Flow | $372 | $395 | $27,000 | $50,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$17,761 | -$3,137 | -$3,137 | -$2,095 |
| Stock Issued | $0 | $29 | $0 | $228 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$17,761 | -$3,108 | -$3,137 | -$1,867 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20,581 | -$25,315 | -$5,463 | $28,882 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77,450 | $102,765 | $108,228 | $79,346 |
| End Cash | $56,869 | $77,450 | $102,765 | $108,228 |
| Free Cash Flow | -$3,192 | -$22,602 | -$29,326 | -$19,251 |